By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ProSensa Holding N.V. 

Wassenaarseweg 72

Leiden    2333 AL  The Netherlands
Phone: 31-71-5274202 Fax: 31-71-5274203


SEARCH JOBS


Industry
Biotechnology






Company News
ProSensa Holding N.V. (RNA) Announces 3rd Quarter 2014 Financial Results And Recent Corporate Developments 11/17/2014 12:02:47 PM
Cure Duchenne And ProSensa Holding N.V. (RNA) To Present Collaboration At Partnering For Cures Conference 11/13/2014 11:07:24 AM
Cure Duchenne And ProSensa Holding N.V. (RNA) To Present Collaboration At Partnering For Cures Conference 11/13/2014 10:35:58 AM
ProSensa Holding N.V. (RNA) To Webcast Conference Call Discussing 3rd Quarter 2014 Financial Results And Corporate Update On November 17, 2014 11/10/2014 7:48:12 AM
ProSensa Holding N.V. (RNA) To Present At Upcoming Investor Conferences 11/7/2014 10:29:12 AM
ProSensa Holding N.V. (RNA) Begins NDA Submission To The FDA For Exon-Skipping Drug Drisapersen To Treat Duchenne Muscular Dystrophy 10/13/2014 7:33:04 AM
ProSensa Holding N.V. (RNA) Begins NDA Submission To The FDA For Exon-Skipping Drug Drisapersen To Treat Duchenne Muscular Dystrophy 10/10/2014 1:47:44 PM
ProSensa Holding N.V. (RNA) Extends The Re-Dosing Of Drisapersen In Europe In Patients With Duchenne Muscular Dystrophy 9/26/2014 7:28:11 AM
ProSensa Holding N.V. (RNA) To Present At Upcoming Conferences 9/25/2014 7:59:11 AM
ProSensa Holding N.V. (RNA) Publishes A Sensitive, Reproducible And Objective Methodology For Dystrophin Analysis In Patients With Duchenne Muscular Dystrophy 9/24/2014 7:38:37 AM
12345678
//-->